Skip to content
← Back to this collection

PUBLICATIONS · 20439641

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Jun 10
First author
van Oers MH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      van Oers MH
      type
      Author
    2. name
      Van Glabbeke M
      type
      Author
    3. name
      Giurgea L
      type
      Author
    4. name
      Klasa R
      type
      Author
    5. name
      Marcus RE
      type
      Author
    6. name
      Wolf M
      type
      Author
    7. name
      Kimby E
      type
      Author
    8. name
      van t Veer M
      type
      Author
    9. name
      Vranovsky A
      type
      Author
    10. name
      Holte H
      type
      Author
    11. name
      Hagenbeek A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      van Oers MH
      type
      Author
    2. name
      Van Glabbeke M
      type
      Author
    3. name
      Giurgea L
      type
      Author
    4. name
      Klasa R
      type
      Author
    5. name
      Marcus RE
      type
      Author
    6. name
      Wolf M
      type
      Author
    7. name
      Kimby E
      type
      Author
    8. name
      van t Veer M
      type
      Author
    9. name
      Vranovsky A
      type
      Author
    10. name
      Holte H
      type
      Author
    11. name
      Hagenbeek A
      type
      Author
    bibliography ids
    1. nci-bib-1d3a9ed5afac846d7de8da2a
    book metadata
    content sha256
    ce4caa455696b556723be8aa06ab84f621cc6ac8d06b99829c48e23779fd5a5d
    document type
    citation
    dois
    1. 10.1200/JCO.2009.26.5827
    electronic publication date
    display
    2010 May 3
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20439641
    immutable id
    pubmed:20439641@ce4caa455696b556723be8aa06ab84f621cc6ac8d06b99829c48e23779fd5a5d
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    17
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2853-8
    volume
    28
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20439641
      provenance
      batch id
      bce21fa556c206e375c2
      provider
      NCBI PubMed ESummary
      record sha256
      9ab9c768063621d05f83986cd5e2714a49d4d3774f4363fc9f98b200936f0340
      response sha256
      280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
      retrieved at
      2026-09-09T23:46:33.526275+00:00
      publication date
      display
      2010 Jun 10
      precision
      day
      year
      2010
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, N.I.H., Extramural
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20439641/
      title
      Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

      Preserved source evidence · Independent clinical review pending · Not medical advice